References
[1]陈美娅, 张 靖, 任建林. 三叶因子3研究进展[J]. 世界华人消化杂志,2008, 16(20): 2267-2273.
[2]Li J, Zhou R, He WC, Xia B. Effects of recombinant human intestinal trefoil factor on trinitrobenzene sulphonic acid induced colitis in rats[J]. Mol Biol Rep, 2011 38(7):4787-4792.
[3]Uematsu S, Akira S. Toll-like receptors and innate immunity[J]. J Mol Med, 2006, 84(9): 712-725.
[4]Peterson CY, Costantini TW, Loomis WH, Putnam JG, Wolf P, Bansal V, et al. Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury[J]. Surg Infect (Larchmt), 2010, 11(2): 137-144.
[5]de Foneska A, Kaunitz JD. Gastroduodenal mucosal defense[J]. Curr Opin Gastroenterol, 2010, 26(6): 604-610.
[6]Lorenz E.TLR2 and TLR4 expression during bacterial infections[J]. Curr Pharm Des, 2006, 12(32): 4185-4193.
[7]吴秀清,王虹,孙梅,吕庆杰,周卓. 幼年大鼠内毒素血症时小肠上皮细胞凋亡及Caspase-3的表达[J]. 中国当代儿科杂志, 2005, 7(2), 167-170.
[8]李军,许玲芬,孙梅,李强,高红,姜卫国. 肠三叶因子在内毒素致幼鼠肠损伤中的作用及意义[J]. 中国当代儿科杂志, 2006, 8(5):425-428.
[9]John LJ, Fromm M, Schulzke JD. Epithelial barriers in intestinal inflammation[J]. Antioxid Redox Signal, 2011, 15(5):1255-1270.
[10]李刚,李幼生,黎介寿. 肠功能障碍的新概念: 急性肠损伤与急性肠伤害综合征[J]. 肠外与肠内营养, 2010,17(5),302-305.
[11]孙勇, 彭曦. 肠三叶因子研究进展[J]. 肠外与肠内营养,2006,13(4):243-246.
[12]周雅芮,张丙宏,严彩霞,张海霞,赵日红. 肠三叶因子对新生鼠坏死性小肠结肠炎模型 Caspase29表达的影响[J]. 实用儿科临床杂志,2009, 24(19):1490-1495.
[13]滕旭,许玲芬,孙梅,吴捷,刘璐. 肠三叶因子对炎症性肠病小鼠细胞凋亡的调节机制[J]. 实用儿科临床杂志,2010,26(13):1028-1031.
[14]付春花, 张丙宏, 严彩霞, 陈丽萍, 麦根荣. 肠三叶因子对新生大鼠坏死性小肠结肠炎的保护作用[J]. 中国当代儿科杂志, 2005, 7(1):20-24.
[15]Renes IB, Verburg M, Van Nispen DJ, Büller HA, Dekker J, Einerhand AW. Distinct epitherial responses in-experimental colitis: implications for ion uptake mucosal protection[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1):G169-G179.
[16]Dunzendorfer S, Lee HK, Soldau K, Tobias PS. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses[J]. FASEB J, 2004, 18(10): 1117-1119.
[17]Ohnishi T, Muroi M, Tanamoto K.The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2[J]. FEMS Immunol Med Microbiol, 2007, 51(1): 84-91.
[18]Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut[J]. J Immunol, 2003, 170(8): 3977-3985.
[19]Uematsu S, Fujimoto K.The innate immune system in the intestine[J]. Microbiol Immunol. 2010,54(11):645-657.
[20]Miyake K.Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: unique roles for MD-2[J]. Int Immunopharmacol, 2003, 3(1): 119-128.
[21]Miyake K.Endotoxin recognition molecules, Toll-like receptor 4-MD-2[J]. Semin Immunol, 2004, 16(1): 11-16.